Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today announced results from new post hoc analyses of the HELIOS-B Phase 3 study of AMVUTTRA® (vutrisiran), an RNAi ...

The adjusted r-squared is helpful for multiple regression and corrects for erroneous regression, giving you a more accurate ...

StandardAero (NYSE:SARO) has seen its stock tick only slightly higher over the past month, reflecting a quiet period without major headlines or announcements for the company. Investors appear to be ...

Female sex at birth, age of 65 years or older, and 32 specific medications were identified as factors for drug-related candidiasis.

Objective Interstitial lung disease (ILD) represents the most common and severe organ manifestation observed in patients ...

Tonight's nine-game slate looks to be a lot of fun. The Ducks and Stars feature multiple lines of young, exciting scorers, ...

The reduction of health inequalities has been a priority of researchers, decision-makers and practitioners for many years.

These scores place it at or near the level of top proprietary systems like GPT-5 (thinking) and Claude Sonnet 4.5, making ...

Medical device makers use AI to turn EU regulatory challenges into competitive advantages via supply chain optimization.